QL
CPRX

Quarry LP’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarry LP’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Buy
+10,000
New +$238K 0.04% 293
2025
Q4 		– Sell
-2,011
Closed -$39.6K – 2220
2025
Q3 		$39.6K Buy
+2,011
New +$41.4K 0.01% 974
2025
Q2 		– Sell
-8,000
Closed -$194K – 1786
2025
Q1 		$194K Buy
8,000
+3,000
+60% +$67.6K 0.04% 308
2024
Q4 		$104K Buy
+5,000
New +$107K 0.01% 432
2024
Q3 		– Sell
-16,334
Closed -$253K – 1718
2024
Q2 		$253K Buy
16,334
+10,284
+170% +$160K 0.07% 130
2024
Q1 		$96.4K Buy
6,050
+5,050
+505% +$76.1K 0.02% 250
2023
Q4 		$16.8K Buy
+1,000
New +$13.7K ﹤0.01% 846

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Quarry LP's CPRX Position: Q1 2026 in Review

Quarry LP opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 10,000 shares worth $248K. The stake represents 0.04% of the portfolio and ranks #293 among its holdings. This is a return to the name: Quarry LP previously reported a position in CPRX as recently as Q3 2025.

Quarry LP first reported a position in CPRX in Q4 2023 and has held it in 7 quarters since. The position peaked at $253K in Q2 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Quarry LP held 10,000 shares of Catalyst Pharmaceutical worth $248K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Quarry LP position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.04% of Quarry LP's portfolio in Q1 2026, its #293 holding.
  • Quarry LP first reported a position in Catalyst Pharmaceutical in Q4 2023 and has held it in 7 quarters since.
  • Quarry LP's Catalyst Pharmaceutical position peaked at $253K in Q2 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.